These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4440110)

  • 1. Quantitative determination of imipramine and desmethylimipramine in human plasma by mass fragmentography.
    Pantarott C; Belvedere G; Frigerio A
    Z Klin Chem Klin Biochem; 1974 May; 12(5):224-5. PubMed ID: 4440110
    [No Abstract]   [Full Text] [Related]  

  • 2. A sensitive method for the simultaneous determination in biological fluids of imipramine and desipramine or clomipramine and N-desmethylclomipramine by gas chromatography mass spectrometry.
    Alkalay D; Volk J; Carlsen S
    Biomed Mass Spectrom; 1979 May; 6(5):200-4. PubMed ID: 476283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatographic-mass fragmentographic determation of "steady-state" plasma levels of imipramine and desipramine in chronically treated patients.
    Belvedere G; Burti L; Frigerio A; Pantarotto C
    J Chromatogr; 1975 Sep; 111(2):313-21. PubMed ID: 1159010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL
    J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel J; Michelson L
    Psychopharmacol Bull; 1984; 20(1):123-5. PubMed ID: 6718637
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry.
    Narasimhachari N; Saady J; Friedel RO
    Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector.
    Cooper TB; Allen D; Simpson GM
    Psychopharmacol Commun; 1975; 1(4):445-54. PubMed ID: 1224013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous depression and imipramine levels in the blood.
    Costa D; Predescu V; Vişan-Ionescu I; Ciurezu T
    Psychopharmacology (Berl); 1980; 70(3):291-4. PubMed ID: 6777803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for the determination of imipramine in human plasma by gas-liquid chromatography-mass fragmentography.
    Frigerio A; Belvedere G; De Nadai F; Fanelli R; Pantarotto C; Riva E; Morselli PL
    J Chromatogr; 1972 Dec; 74(2):201-8. PubMed ID: 4645668
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with Petylyl (desipramine) in antidepressive therapy. Double blind test with Pryleugan (imipramine)].
    Kühne GE; Knorr W; Perina L; Richter H; Rommel B; Sorger R; Waldow N; Fabiano B; Blosfeld G; Stöck H
    Z Arztl Fortbild (Jena); 1976 Aug; 70(15):835-9. PubMed ID: 790788
    [No Abstract]   [Full Text] [Related]  

  • 13. An explanatory statistical model for plasma levels of imipramine and desmethylimipramine during long-term therapy.
    Roberts CD; Roberts EN
    Br J Psychiatry; 1973 Jun; 122(571):736-7. PubMed ID: 4716078
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative clinical-experimental studies on imipramine and desipramine].
    Fischbach R
    Wien Med Wochenschr; 1967 Oct; 117(41):922-6. PubMed ID: 5588060
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on plasma level/effect relationships in imipramine therapy.
    Perel JM; Stiller RL; Glassman AH
    Commun Psychopharmacol; 1978; 2(5):429-39. PubMed ID: 738021
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma imipramine and desmethylimipramine concentration and clinical response in childhood enuresis.
    Rapoport JL; Mikkelsen EJ; Zavadil AP
    Psychopharmacol Bull; 1978 Oct; 14(4):60-1. PubMed ID: 704764
    [No Abstract]   [Full Text] [Related]  

  • 18. High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites.
    Sutfin TA; Jusko WJ
    J Pharm Sci; 1979 Jun; 68(6):703-5. PubMed ID: 458567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J; Albin H; França X; Vinçon G; Démotes-Mainard F
    Ann Med Psychol (Paris); 1988; 146(8):764-72. PubMed ID: 3242402
    [No Abstract]   [Full Text] [Related]  

  • 20. [The association of imipramine and desipramine in the treatment of depressions].
    Spina A
    Acta Neurol (Napoli); 1971; 26(4):490-5. PubMed ID: 5132829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.